Skip to main content
Top
Published in: Cancer Causes & Control 6/2005

01-08-2005

Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Authors: Joanne Kotsopoulos, Jan Lubinski, Henry T. Lynch, Susan L. Neuhausen, Parviz Ghadirian, Claudine Isaacs, Barbara Weber, Charmaine Kim-Sing, William D. Foulkes, Ruth Gershoni-Baruch, Peter Ainsworth, Eitan Friedman, Mary Daly, Judy E. Garber, Beth Karlan, Olufunmilayo I. Olopade, Nadine Tung, Howard M. Saal, Andrea Eisen, Michael Osborne, Hakan Olsson, Dawna Gilchrist, Ping Sun, Steven A. Narod

Published in: Cancer Causes & Control | Issue 6/2005

Login to get access
Metadata
Title
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Authors
Joanne Kotsopoulos
Jan Lubinski
Henry T. Lynch
Susan L. Neuhausen
Parviz Ghadirian
Claudine Isaacs
Barbara Weber
Charmaine Kim-Sing
William D. Foulkes
Ruth Gershoni-Baruch
Peter Ainsworth
Eitan Friedman
Mary Daly
Judy E. Garber
Beth Karlan
Olufunmilayo I. Olopade
Nadine Tung
Howard M. Saal
Andrea Eisen
Michael Osborne
Hakan Olsson
Dawna Gilchrist
Ping Sun
Steven A. Narod
Publication date
01-08-2005
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 6/2005
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-1724-1

Other articles of this Issue 6/2005

Cancer Causes & Control 6/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine